TABLE 5.

Hepatic diglyceride fatty acid composition in NASH and antioxidant treatment

VitE	Chow		WD for 8 weeks		WD for 20 weeks
	(−)	(+)	(−)	(+)	(−)	(+)
14:0	0.88 ± 0.08	0.88 ± 0.21	1.22 ± 0.04a	1.51 ± 0.13b	1.08 ± 0.06	1.07 ± 0.05
16:0	35.84 ± 1.18	36.20 ± 1.77	39.34 ± 0.58a	39.87 ± 0.79	35.06 ± 0.80c	35.40 ± 0.95
16:1	3.56 ± 0.20	3.80 ± 0.16	4.98 ± 0.15a	4.66 ± 0.23	5.08 ± 0.17a	4.62 ± 0.16
18:0	5.53 ± 0.52	9.58 ± 0.90b	5.03 ± 0.41	7.55 ± 1.02b	5.10 ± 0.91	4.58 ± 0.26
18:1ω9	44.57 ± 1.63	40.02 ± 2.36	37.57 ± 0.67a	35.38 ± 1.13	39.57 ± 1.09a	42.67 ± 1.37
18:1ω7	5.35 ± 0.56	5.56 ± 0.13	10.57 ± 0.24a	9.10 ± 0.81	12.65 ± 0.41a,c	10.84 ± 0.27b
18:2	4.28 ± 0.50	3.96 ± 0.40	1.28 ± 0.06a	1.93 ± 0.60	1.08 ± 0.27a	0.81 ± 0.10

Data are means (% of lipid composition) ± SEM, n = 8–11 mice.

^aP < 0.05 versus chow.

^bP < 0.05 versus no VitE treatment, same diet.

^cP < 0.05 versus WD for 8 weeks.